Gerald E. Quirk - 11 Oct 2022 Form 3 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Reporting relationship: Chief Legal Officer
Issuer ticker: SYRS
Reported as of: 11 Oct 2022
Net transaction value: $0
SEC form: 3
Accepted by SEC: 13 Oct 2022, 16:15:50 UTC
Next SEC filing: 14 Sep 2023
Source filing: View source filing
Reporting owner signature: /s/ Todd Rosenthal, as attorney-in-fact

Key filing fact

Gerald E. Quirk filed Form 3 for Syros Pharmaceuticals, Inc. (SYRS) on 13 Oct 2022.

Key facts

This page summarizes Gerald E. Quirk's Form 3 filing for Syros Pharmaceuticals, Inc. (SYRS).
0 reported transactions and 6 derivative rows are listed below.
Accepted by SEC: 13 Oct 2022, 16:15.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SYRS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,700
Date: 11 Oct 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SYRS holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 11 Oct 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,998
Exercise price: $133.00
Footnotes: F1

SYRS holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 11 Oct 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,999
Exercise price: $109.00
Footnotes: F1

SYRS holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 11 Oct 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,499
Exercise price: $100.90
Footnotes: F1

SYRS holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 11 Oct 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,718
Exercise price: $67.10
Footnotes: F1

SYRS holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 11 Oct 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,069
Exercise price: $75.40
Footnotes: F1

SYRS holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 11 Oct 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,719
Exercise price: $114.10
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option is fully vested.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .